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in particular, the rotational atherectomy and cutting balloon, this
group of patients can be treated with percutaneous intervention. This
study was to review the safety and efﬁcacy of rotablator and cutting
balloon in our practice.
METHODS From January 2012 to December 2013, all consecutive pa-
tients who received rotational atherectomy for heavily calciﬁed left
main coronary disease in our cath lab were enrolled. All clinical and
angiographic characteristics as well as information regarding rota-
tional atherectomy and cutting balloon were retrieved and analyzed.
RESULTS A total number of 8 patients were recruited with a mean age
77.6 +/- 9. There were 75% presented with stable angina, 12.5% with
acute coronary syndrome and 12.5% with cardiogenic shock. Chronic
renal disease was seen in 25%, diabetes mellitus in 50% and hyper-
tension in 100%. The angiographic and procedural success rate was
100%. The number of burrs used per patient was 1.3+/-0.4 and burr
size was 1.75+/-0.25. The cutting balloon size was 2.34+/-0.7. Most
stents were drug-eluting stent 87%. The techniques used for bifur-
cation stenting were culotte (62.5%), mini-crush (25%) and provisional
(12.5%). Intra-aortic balloon pump was used in 25%. There was no
complication among our cases.
CONCLUSION Heavily calciﬁed left main coronary disease treated
with rotational atherectomy, cutting balloon and stent is feasible and
safe with high angiographic and procedural success rate.
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BACKGROUND The mortality of patients (pts) admitted with acute
myocardial infarction (AMI) remains high despite improvement in all
aspects of cardiac care. This mortality is even higher in pts who
require index left main (LM) revascularization at the time of admis-
sion. We sought to investigate the predictors of in-hospital and 2-year
mortality in such pts.
METHODS This study is single center, retrospective, observational
and registry-based study. All pts admitted for AMI as deﬁned in the
“Third Universal Deﬁnition of Myocardial Infarction” and fulﬁlled the
inclusion and exclusion criteria was enrolled. A total of 212 AMI pts
were screened from our institutional LM stenting registry and we
identiﬁed 75 pts among this cohort who successfully underwent
emergency revascularization of the LM disease.
RESULTS A total of 75 AMI pts with signiﬁcant LM disease were
enrolled. Male was in 77.3%. There were 47 (62.7%) ST-segment
elevation myocardial infarction (STEMI). Cardiogenic shock was pre-
sent in 12.0% of the pts and signiﬁcant number of pts required IABP
insertion. Clinical and Angiographic success was achieved in 100% of
the patients. Overall, the in-hospital mortality remained high at 17.3%
due to overt heart failure, cardiogenic shock and multi-organs func-
tion. 13 Major cardiovascular events (MACE) were recorded during
hospitalization including death, myocardial infarction, and stent
thrombosis and target vessel revascularization. From the multiple
regression analysis, cardiogenic shock at presentation and the renal
dysfunction remained a good predictor of in-hospital and 2-year
mortality for in-hospital survivors. Prognosis for pts in cardiogenic
shock remained grave with 77.8% of in-hospital mortality. At 2-year
follow up, in-hospital survivor has a mortality of 11.3%whereas addi-
tional 22 experienced MACE.
CONCLUSION Pts with LM disease required stenting at the time of
AMI is uncommon but is associated with high in-hospital and 2-years
mortality especially in those presenting with cardiogenic shock and
renal dysfunction.TCTAP A-039
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BACKGROUND Final kissing balloon inﬂation (KBI) is generally
accepted as a technique to expand the side branch (SB) and proximal
main vessel (MV) simultaneously after cross-over stenting in the
coronary bifurcation lesion. The prior bench testing, however,
revealed that the KBI causes an asymmetric oval deformation of the
proximal MV stent. The Glider balloon (GB) (Tri Reme Medical,
Pleasanton, CA, U.S.A) is a dedicated SB balloon designed for optimal
SB ostial expansion with minimizing the MV stent deformation. We
investigated the efﬁcacy of the GB in the present study.
METHODS We analyzed consecutive 19 patients who undertook
elective bifurcation stenting with SB dilation using the GB and prox-
imal optimization technique (POT) (mean age; 71  2 year-old, man /
female ¼ 17 / 2). The lesion location was LMT / LAD / LCx / RCA ¼ 9 / 7 /
1 / 2. The 2.5 / 4 mm and 3.0/ 4 mm GB balloons were used in 12 and 7
cases, respectively. We evaluated the eccentricity index (short / long
lumen diameter) and cross sectional area (CSA) in the SB ostium,
proximal and distal MV at the bifurcation and the reference sites using
IVUS or OCT or OFDI.
RESULTS The eccentricity index at the bifurcation site was not statis-
tically different from that at the reference site in each branch (distalMV;
0.900.01 vs. 0.900.01, SB; 0.860.02 vs. 0.880.02, proximalMV;
0.89  0.01 vs. 0.91  0.01, versus reference site). In addition, the CSA
was not statistically different in each site compared with that of each
reference site (distal MV; 7.77 0.53 vs. 7.33 0.51 mm2, SB; 6.67 0.73
vs. 5.74  0.52 mm2, proximal MV; 8.94  0.47 vs. 9.79  0.61 mm2,
versus reference site). The mean percentage of lumen CSA gain of the
proximal MV compared to the distal MVwas 388%, which was similar
as that induced by the KBI in the previous report.
CONCLUSION These data indicate that the SB dilatation by the GB
combined with POT could provide symmetrical and sufﬁcient
expansion in each branch without any signiﬁcant deformation of the
MV stent.
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BACKGROUND Percutaneous coronary interventions with standard
balloon or bare metal stent for bifurcational lesion carry a signiﬁcant
restenosis rate of both vessels. The use of the drug eluting stent (DES)
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main branch with regular balloon for the side branch did not show
signiﬁcant improvement at 6/12 follow up particularly for the side
branch which still show signiﬁcant rate of restenosis. In bifurcation
lesion with signiﬁcant stenosis of both branches, the restenosis of side
branch is high with either provisional or two stent techniques (15%).
Recent reports suggest that drug eluting balloon (DEB) might improve
the current result of side branch treatment. We perform this study to
evaluate outcome of the percutaneous coronary intervention (PCI)
with DES for main branch & DEB for side branch with bifurcational
coronary artery disease.
METHODS This study enrolled 80 patients with coronary artery bifur-
cation lesions, 50 were males & 30 were females with a mean age of
608 years. Thirty patients had hyperlipidemia and 48 had diabetes
mellitus. The involved vessels included left anterior descending/diag-
onal (56), circumﬂex/obtuse marginal (16) and right coronary artery/
posterior descending or posteriolateral (8). All patients receivedDES for
main branch PCIwith paclitaxel DEB for the side branch. 50 patients had
stable angina and 30 had unstable angina or silent ischemia. Patients
with left main bifurcational lesion and patient with severe left ven-
tricular dysfunction (ejection fraction > 25%)were excluded. At 6
months follow-up, coronary angiogram was performed in 40 patients,
nuclear image in 28 patients and the remaining 12 were followed-up
clinically. The mean size and length were 2.75  0.5 and 18.0  6.0 mm
for the used DES and 2.22  0.23 and 18.0  8.0 mm for the used DEB.
RESULTS Procedure success was achieved in all patients. The Pre-PCI
diameter stenoses for themain branch and for the side branchwere 85
12% and 8010%, respectively. They became 57% and 1510% imme-
diately after the procedure and 156% and 3010% at 6-12 month
follow-up. Dissection of the posterolateral branch with residual reste-
nosis of 60% occurred in one patient during dilatation with DEB, which
was treatedwithDESwith good result. No acute or sub-acute thrombosis
was noticed in any of the studied patients. The incidences of restenosis
and of major adverse cardiac events at follow-up were 5% and 6.25%,
respectively. Restenosis occurred in 2 patients with circumﬂex/obtuse
marginal and in 2 patients with left anterior descending /diagonal dila-
tation. 2 were treated with coronary artery bypass surgery and the other
twowere treatedmedically. No deathwas observed in any of the studied
patients during the 12 month follow-up period.
CONCLUSION This study demonstrates that the technique of using
DES for the main branch and DEB for the side branch for the treatment
of bifurcational lesions is safe and effective with a low incidence of
restenosis and major adverse cardiac events at immediate and six-
twelve months follow-up.
TCTAP A-143
Clinical Outcome of Aorto-Ostial Coverage in Patients Following
Implantation of Drug Eluting Stents in Unprotected Left Main Coronary
Artery: 2-Year Results from the ASAN-MAIN Registry
Seung-Jung Park,1 Min Su Kim,1 Se Hun Kang,1 Hee-soon Park,1
Byeong Joo Bae,1 Sang Soo Cheon,1 Jae Hyung Roh,1 Pil Hyung Lee,1
Mineok Chang,1 Hyun Woo Park,1 Sung Han Yoon,1 Jung-Min Ahn,1
Duk-Woo Park,1 Soo-Jin Kang,1 Seung-Whan Lee,1 Young-Hak Kim,1
Cheol Whan Lee,1 Seong-Wook Park1
1Asan Medical Center, Korea (Republic of)
BACKGROUND The aim of this study was to compare the impact on
clinical outcome of unprotected left main coronary artery (ULMCA)
aorto-ostial coverage (AOC) with DES.
METHODS A total of 3041 patients with signiﬁcant ULMCA
stenosis were enrolled in ASAN-MAIN registry. We identiﬁed 861
(28.3%) with ULMCA treatment with DES, who were categorized into
stenting with AO coverage (AOC, N¼623) versus stenting without AOC
(N¼238).
RESULTS Angiographic follow up was obtained in 630 (73.1%) patient.
No AOC group showed more chronic total occlusion (2.9% vs. 1.0%;
p¼0.033) and more ulcerative lesions (4.6% vs.2.1%; p¼0.043). In
patients of the AOC group had more aorto-ostial lesion (49.3% vs.
2.1%; p¼ <0.001). During 2-year follow-up, all-cause mortality, MI,
TVR and TLR did not show statistically signiﬁcant differences. LM ISR
did not differ between groups (4.2% in No AOC group vs. 6.9% in AOC
group; p¼0.29).LM ostial ISR occurred 8 patients (1.28%) in AOC group
and de novo LM ostial stenosis occurred 4 patients (1.68%) in No AOC
group. After Cox regression multivariable analysis, AOC did not affect
the cardiac death (HR 1.86, 95% CI 0.57 to 6.05; p¼ 0.30).
CONCLUSION AOC of the ULMCA with DES is safe, which did not
affect clinical outcomes or ISR.Table 1. Characteristics of Study Patients Undergoing PCI of the ULMCANo AOC (N[238) AOC (N[623) P-valueAge (years) 62.3410.97 63.929.47 0.231Gender (Male) 45(18.9) 174(27.9) 0.007Hypertension 144(60.5) 356(57.1) 0.371Diabetes 85(35.7) 216(34.7) 0.774LV ejection fraction (%) 57.39.72 59.67.64 0.035Aorto-ostial lesion 5(2.1) 307(49.3) 0.001At least one chronic total occlusion 7(2.9) 6(1) 0.033At least one severe calciﬁcation 14(5.9) 21(3.4) 0.095At least one thrombus present 12(5) 26(4.2) 0.579At least one ulceration 11(4.6) 13(2.1) 0.043Reference diameter (mm) 3.580.44 3.70.42 0.001Lumen diameter stenosis (%) 61.8332.8 64.7926.5 0.171Total number of stents 2.891.4 2.681.5 0.301Total stent length 70.3239.7 63.0838.1 0.158Maximal balloon inﬂation size 3.940.3 4.080.4 0.004Data are N (%), meanSD); AOC, aorto-ostial coverage
(Freedom From All-cause Mortality in the AOC Group Versus the No
AOC Group for ULMCA).CELL THERAPY AND ANGIOGENESIS (TCTAP A-041)
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BACKGROUND Ischemia-related inﬂammation is the most critical fac-
tor for the survival of transplanted mesenchymal stem cells (MSCs).
Strategies of keeping excessive inﬂammation in control after acute
myocardial infarction (AMI) are necessary and essential for the survival
of transplanted MSCs. Our study was to test whether decreased
Ly6Chigh monocytes beneﬁted mouse MSCs transplantation post-AMI.
METHODS BALB/c AMI mice were systemically treated with CCR2
antagonist (RS504393, 2mg/kg, Tocris) or normal saline (controlgroup).
105 EdU-labeled (Invitrogen) MSCs were administered to mice in both
groups by intramyocardial injection.We used Tunel kits (R&D Systems)
to identify the apoptotic cardiomyocytes in the infarct zone. And slides
of the infarcts were stainedwithWheat GermAgglutinin (Invitrogen) to
measure vessel density. Anti-Myosin Heavy Chain eFluor 660 (eBio-
science) was utilized to measure cardiac myosin-positive area. Trans-
well chambers (Corning) were introduced to examine the interactions
between MSCs and Ly6Chigh monocytes. Inﬂammatory cytonkines
expressed by Ly6Chigh monocytes and SDF-1 secreted by MSCs were
detected with Elisa Kits (R&DSystems). MSCs viability was further
